 LONDON, UK ACCESSWIRE December 16, 2019 Midatech MTPH.LMTP, an RD; biotechnology company focused on delivering innovative oncology and rare disease products, announces that it received written notification the Notification Letter from The NASDAQ Stock Market LLC NASDAQ, dated 11 December 2019, stating that the Company is not in compliance with the minimum bid price requirement set forth in NASDAQs rules for continued listing on The NASDAQ Capital Market. NASDAQ Listing Rule 5550a2 requires listed securities to maintain a minimum bid price of 1.00 per share, and Listing Rule 5810c3A provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. 